Phase II trials of a GM-CSF gene-transduced prostate cancer cell line vaccine (GVAX) in hormone refractory prostate cancer. - Simons,J.; Nelson,W.; Nemunaitis,J.; Centeno,A.; Dula,E.; Urba,W.; Smith,D.; Marshall,F.; Howard,C.; Ando,D.; Small,E. (Proc Am Soc Clin Oncol, 2002)